93 Results (Page 1 of 4)
South Korea Markets Research Reports
South Korea COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the South Korean COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Korean COVID-19 Clinical Trials Market, offering unmatched value, accuracy, and expert insights.
South Korea Over The Counter (OTC) Pharmaceuticals Market Analysis
South Korea's over-the-counter (OTC) pharmaceuticals market size was valued at $2009.1 Mn in 2022 and is estimated to expand at a CAGR of 6.54% from 2022 to 2030 and will reach $3335 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
South Korea Digital Therapeutics Market Analysis
This report presents a strategic analysis of the South Korea Digital Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Korea Digital Therapeutics Market, offering unmatched value, accuracy, and expert insights.
South Korea Cardiovascular Drugs Market Analysis
South Korea Cardiovascular Drug Market is at around $2.02 Bn in 2022 and is projected to reach $2.94 Bn in 2030, exhibiting a CAGR of 4.8% during the forecast period. The main elements propelling this industry's growth include the incidence of cardiovascular diseases, changing lifestyles, and government programs. The market is dominated by key players like Hanmi Pharmaceutical, Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, Merck & Co., Inc., Gilead Sciences, Inc., and F. Hoffmann-La Roche Ltd.
South Korea Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the South Korea Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korea Vitamin and Minerals Market reports, offering unmatched value, accuracy, and expert insights.
South Korea Virtual Clinical Trials Market Analysis
This report presents a strategic analysis of the South Korea Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korea Virtual Clinical Trials Market reports, offering unmatched value, accuracy, and expert insights.
South Korea Sleep Disorders Market Analysis
This report presents a strategic analysis of the South Korea Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Korea Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
South Korea Retail Pharmacy Market Analysis
This report presents a strategic analysis of the South Korean retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korean retail Pharmacy Market reports, offering unmatched value, accuracy, and expert insights.
South Korea Radiotherapy Market Analysis
By 2030, it is anticipated that the South Korea Radiotherapy Market will reach a value of $173 Mn from $101 Mn in 2022, growing at a CAGR of 7% during 2022-30. The Radiotherapy Therapeutics Market in South Korea is dominated by a few domestic players such as HANRAY, Dongbang Medical, and Neusoft Medical Systems Korea. The radiotherapy market in South Korea is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for South Korea Radiotherapy is increasing on account of the rise in cancer cases in the country.
South Korea Patient Support Programs (PSP) Market Analysis
This report presents a strategic analysis of the South Korea Patient Support Programs (PSP) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korea Patient Support Programs (PSP) Market reports, offering unmatched value, accuracy, and expert insights.
South Korea Obesity Drugs Market Analysis
This report presents a strategic analysis of the South Korea Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Korea Obesity Drugs Market, offering unmatched value, accuracy, and expert insights.
South Korea Medical Devices Market Analysis
This report presents a strategic analysis of the South Korea Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korea Medical Devices Market reports, offering unmatched value, accuracy, and expert insights.
South Korea In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of the South Korea In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Korea In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy, and expert insights.
South Korea Home Healthcare Market Analysis
South Korea's home healthcare market was valued at $5.29 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $10.50 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the increased prevalence of chronic ailments. The market is segmented by equipment outlook and by services. Some key players in this market are BAYDA Home Healthcare, Samsung Medical Centre, Seoul National University Hospital, Asan Medical Center, and the National Health Insurance Service (NHIS).
South Korea ENT Devices Market Analysis
South Korean ENT Devices Market is projected to grow from $340 Mn in 2022 to $570 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the South Korean ENT devices market include Otosys, MediVision, and NeomediTech.
South Korea ECG Equipments Market Analysis
South Korean ECG Equipment Market is expected to witness growth from $130 Mn in 2022 to $246 Mn in 2030 with a CAGR of 8.30% for the forecasted year 2022-30. In South Korea, there is an increasing awareness of the value of early diagnosis and prevention of heart disease, which has resulted in the establishment of numerous screening programs and initiatives. Due to this, there is no more need for ECG equipment as a screening tool for heart disease early detection. The market is segmented by product type and by end user. Some key players in this market include Nanoomtech, L&K Biomed, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
South Korea Dermatology Drugs Market Analysis
By 2030, it is anticipated that the South Korean Dermatology drugs market will reach a value of $606 Mn from $248 Mn in 2022, growing at a CAGR of 11.8% during 2022-30. The market is primarily dominated by local players such as CosmoFarma Korea, JW Pharmaceuticals, and Samjeong Pharma. The market is driven by locally produced drugs, awareness about dermatological health, and government regulations. The dermatology drug market in South Korea is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
South Korea Dermatological Therapeutics Market Analysis
This report presents a strategic analysis of the South Korean dermatological Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korean dermatological Therapeutics Market reports, offering unmatched value, accuracy, and expert insights.
South Korea Coronary Stents Market Analysis
South Korea's Coronary Stents Market is expected to witness growth from $165 Mn in 2022 to $258 Mn in 2030 with a CAGR of 5.75% for the forecasted year 2022-30. In South Korea, the frequency of coronary artery illness is increasing which is anticipated to increase demand for coronary stents. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Nanoomtech, Kolon Life Science, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, Transmedia Healthcare, and Philips Healthcare.
South Korea Contraceptive Devices Market Analysis
South Korea's Contraceptive Devices Market is expected to witness growth from $188 Mn in 2022 to $376 Mn in 2030 with a CAGR of 9.00% for the forecasted year 2022-30. In recent years, South Korea has become more aware of and accepting of family planning and the use of contraceptives. The demand for these devices has increased as a result. The market is segmented by type and by gender. Some key players in this market include Hanmi Pharm, Dong-A ST, Bukwang Pharmaceutical, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
South Korea Breast Cancer Therapeutics Market Analysis
The market for South Korean breast cancer therapeutics is expected to witness a rise from $266 Mn in 2022 to $753 Mn in 2030 with a CAGR of 13.9% for the period 2022-30 most probably due to the rise in sedentary lifestyle choices in South Korea and introduction of more sophisticated treatment options. The market is segmented by therapy, by cancer type, and by distribution channel. Hanmi Pharmaceuticals Co Ltd, Daewoong Pharmaceutical Co Ltd, and Eli Lilly are some major competitors in the South Korean breast cancer therapeutics market.
South Korea Acne Therapeutics Market Analysis
This report presents a strategic analysis of the South Korean Acne Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korea Acne Therapeutics Market reports, offering unmatched value, accuracy, and expert insights.
South Korea Acne Drugs Market Analysis
This report presents a strategic analysis of the South Korean acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive South Korean acne drug market reports, offering unmatched value, accuracy, and expert insights.
South Korea Vaccines Market Analysis
This report presents a strategic analysis of the South Korean vaccine market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the South Korean vaccine market, offering unmatched value, accuracy, and expert insights.
South Korea Physiotherapy Market Analysis
South Korea's physiotherapy market size was valued at $0.77 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.85% from 2022 to 2030 and will reach $1.32 Bn in 2030. The South Korean physiotherapy market is expected to grow due to the increasing prevalence of chronic diseases and lack of awareness of physiotherapy. The market is segmented by Product Type, Application Type, and End User. The major players in the South Korean physiotherapy market are Medi-Ject Co., Ltd, Sun Medical Equipment Co., Ltd, Hanyang Medical, BTL Industries, and others.